Tumor Ablation Market Size Worth $4.08 Billion By 2030

May 2022 | Report Format: Electronic (PDF)

Tumor Ablation Market Growth & Trends

The global tumor ablation market size is expected to reach USD 4.08 billion by 2030, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 13.5% from 2022 to 2030. The increasing incidence of cancer and the high demand for effective treatment options are the major factors driving the market. According to Cancer Research UK, the incidence rate of cancer is expected to grow by 62% from 2018 to 2040. Lung, breast, bowel, and prostate are the most common sites reported with cancer in 2018.

Increasing inclination towards minimally invasive procedures owing to the benefits such as speedy recovery, patient comfort, and shorter turnaround time are the factors expected to foster the demand for advanced tumor ablation techniques during the forecast period. The integration of tumor ablation devices with efficient interventional imaging modalities such as ultrasound, MRI, and CT is anticipated to revolutionize ablation procedures performed in outpatient settings. This is expected to significantly eliminate the cost to the patient including hospital stays.

Supportive government initiatives such as screening programs, awareness campaigns, and cancer schemes for various cancer types are expected to increase the number of diagnosed cases. For instance, in 2019, the National Health Scheme (NHS) started offering lung cancer screening programs in some areas of England. Such initiatives are anticipated to escalate the need for cancer management in early cancer stages, thereby facilitating the demand for tumor ablation therapy.

The rising demand for advanced medical technologies, coupled with improving financing capabilities of healthcare facilities, is expected to increase the demand for tumor ablation devices during the forecast period. For instance, Maimonides Medical Centre, New York announced the purchase of advanced High Intensity Focused Ultrasound (HIFU) ablation device (Focal One by EDAP TMS SA) in 2019 and it has become the second hospital in the U.S. to be equipped with HIFU technology.

key Request a free sample copy or view the report summary: Tumor Ablation Market Report

Tumor Ablation Market Report Highlights

  • The radiofrequency ablation technology segment dominated the market with more than 35.0% share in 2021 owing to its prominent application in solid tumor removal

  • By treatment, percutaneous ablation is expected to witness lucrative growth over the forecast period due to the rising demand for minimally invasive procedures offering faster recovery and higher safety

  • Tumor ablation in lung cancer treatment is anticipated to witness the fastest growth over the forecast period

  • A sedentary lifestyle, increasing incidences of smoking, and rising air pollution are contributing to the growing prevalence of lung cancer

  • North America dominated the market in 2021 owing to the factors such as the increasing prevalence of cancer, high purchasing power parity, government support for quality healthcare, and the availability of reimbursement

Tumor Ablation Market Segmentation

Grand View Research has segmented the global tumor ablation market based on technology, treatment, application, and region:

Tumor Ablation Technology Outlook (Revenue, USD Million, 2017 - 2030)

  • Radiofrequency Ablation

  • Microwave Ablation

  • Cryoablation

  • Irreversible Electroporation

  • Other Ablation Technologies

Tumor Ablation Treatment Outlook (Revenue, USD Million, 2017 - 2030)

  • Surgical Ablation

    • Kidney Cancer

    • Liver Cancer

    • Breast Cancer

    • Lung Cancer

    • Prostate Cancer

    • Other Cancers

  • Laparoscopic Ablation

    • Kidney Cancer

    • Liver Cancer

    • Breast Cancer

    • Lung Cancer

    • Prostate Cancer

    • Other Cancers

  • Percutaneous Ablation

    • Kidney Cancer

    • Liver Cancer

    • Breast Cancer

    • Lung Cancer

    • Prostate Cancer

    • Other Cancers

Tumor Ablation Application Outlook (Revenue, USD Million, 2017 - 2030)

  • Kidney Cancer

  • Liver Cancer

  • Breast Cancer

  • Lung Cancer

  • Prostate Cancer

  • Other Cancer

Tumor Ablation Regional Outlook (Revenue, USD Million, 2017 - 2030)

  • North America

    • U.S.

    • Canada

  • Europe

    • U.K.

    • Germany

    • France

    • Italy

    • Spain

    • Russia

    • Netherland

    • Switzerland

    • Belgium

    • Hungary

  •  Asia Pacific

    • Japan

    • China

    • India

    • Thailand

    • South Korea

    • Taiwan

    • Singapore

    • Malaysia

    • Indonesia

    • Philippines

  • Latin America

    • Brazil

    • Mexico

    • Argentina

    • Colombia

    • Chile

  • Middle East & Africa

    • South Africa

    • Saudi Arabia

    • UAE

    • Turkey

    • Israel

List of Key Players in Tumor Ablation Market

  • Angiodynamics (Covidien)

  • Boston Scientific Corporation

  • Medtronic Plc

  • Ethicon, Inc.

  • Galil Medical Inc.

  • Misonix Inc.

  • HealthTronics

  • Mermaid Medical

  • Theraclion

  • Chongqing Haifu Medical Technology Co., Ltd.

  • HS Hospital Service S.P.A


Pricing & Purchase Options

Service Guarantee

Buy Chapters or Sections

Avail customized purchase options to meet your research needs:

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities

Related Market Research